SCHEMBL30095309

SCHEMBL30095309

Cc1cc(NC(=O)c2cc(C(=O)C(=O)NC(C)(C)C)n(C)c2)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ HTT P42858 2/20 0.39
▸ MAOB P27338 3/20 0.38
▸ MAOA P21397 2/20 0.38
▸ ACKR3 P25106 2/20 0.38
▸ BACE1 P56817 1/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ THRB P10828 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21809721 1.00 NPC1 (0.41) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL16416815 0.91 BACE1 (0.43) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL21916524 0.87 MAPT (0.37) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL21427905 0.85 GRM4 (0.44) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL30093994 0.85 GRM4 (0.44) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL21809600 0.85 NPC1 (0.44) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL16417092 0.82 RAB9A (0.48) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL16421481 0.81 BACE1 (0.42) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL16416930 0.81 BACE1 (0.40) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL21809964 0.80 NPC1 (0.44) NPC1RAB9AMAPTSMN1; SMN2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230062975-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS SPRING MILL PHARMA, INC. 2023-03-02 — — US disclosed
US-11566001-B2 Hepatitis B capsid assembly modulators VenatoRx Pharmaceuticals, Inc. (US) 2023-01-31 — — US disclosed
US-20220298110-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS SPRING MILL PHARMA, INC. 2022-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230062975-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS HAVCR2, COPB1, HDLBP NPC1 117/4885RAB9A 1300/4885MAPT 1087/4885
US-11566001-B2 Hepatitis B capsid assembly modulators HAVCR2, COPB1, HDLBP NPC1 117/4885RAB9A 1300/4885MAPT 1087/4885
US-20220298110-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS HAVCR2, COPB1, HDLBP NPC1 117/4885RAB9A 1300/4885MAPT 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback